Environment-mediated drug resistance: a major contributor to minimal residual disease

Meads, Mark B., Gatenby, Robert A., Dalton, William S.·2009·Nature Reviews Cancer
DOI 10.1038/nrc2714

Cited by (892)

Items 101–200 of 892

  1. Targeting apoptosis pathways in pancreatic cancer
    Alexander Arlt, Susanne Sebens Müerköster, H. Schäfer · 2010 · Cancer Letters
  2. Fibroblast-mediated drug resistance in cancer
    Kim H.T. Paraiso, Keiran S.M. Smalley · 2013 · Biochemical Pharmacology
  3. Bone marrow stroma‐mediated resistance to FLT 3 inhibitors in FLT 3‐ ITD AML is mediated by persistent activation of extracellular regulated kinase
    Xiaochuan Yang, Amy N. Sexauer, Mark J. Levis · 2013 · British Journal of Haematology
  4. The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance
    Bikash Chandra Jena, Siddik Sarkar, Lipsa Rout, Mahitosh Mandal · 2021 · Cancer Letters
  5. Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
    Rehman Ata, Costin N. Antonescu · 2017 · International Journal of Molecular Sciences
  6. Drug uptake-based chemoresistance in breast cancer treatment
    Helena Muley, Rut Fadó, Rosalía Rodríguez‐Rodríguez, Núria Casals · 2020 · Biochemical Pharmacology
  7. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
    Tripti Khare, Marc Bissonnette, Sharad Khare · 2021 · International Journal of Molecular Sciences
  8. An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy
    Hachey, Stephanie J., Movsesyan, Silva, Nguyen, Quy H., Burton-Sojo, Giselle, Tankazyan, Ani, Wu, Jie, Hoang, Tuyen, Zhao, Da, Wang, Shuxiong, Hatch, Michaela M. et al. · 2021 · Lab on a Chip
  9. A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
    Robert Zygmunt Orlowski, Liana Gercheva, C. D. Williams, Heather J. Sutherland, Tadeusz Robak, Tamás Masszi, Vesselina S Goranova-Marinova, Meletios Athanasios Dimopoulos, James D. Cavenagh, Ivan Špıčka et al. · 2014 · American Journal of Hematology
  10. The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
    Yoshiro Itatani, Kenji Kawada, Susumu Inamoto, Takamasa S. Yamamoto, Ryotaro Ogawa, Makoto Mark Taketo, Yoshiharu Sakai · 2016 · International Journal of Molecular Sciences
  11. Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma
    Tasnim Ara, Rie Nakata, Michael Allen Sheard, Hiroyuki Shimada, Ralf Buettner, Susan G. Groshen, Lingyun Ji, Hua Yu, Richard Jove, Robert C. Seeger et al. · 2013 · Cancer Research
  12. Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
    Andriy Marusyk, Doris P. Tabassum, Michalina Janiszewska, Andrew E. Place, Anne C. Trinh, Andrii I. Rozhok, Saumyadipta Pyne, Jennifer L. Guerriero, Shaokun Shu, Muhammad B. Ekram et al. · 2016 · Cancer Research
  13. SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway
    Biao zeng, Ming Zhou, Huan Wu, Zheng-ai Xiong · 2018 · OncoTargets and Therapy
  14. The Evolution and Ecology of Resistance in Cancer Therapy
    Robert A. Gatenby, Joel S. Brown · 2017 · Cold Spring Harbor Perspectives in Medicine · Retracted
  15. Metformin is synthetically lethal with glucose withdrawal in cancer cells
    Javier Abel Menéndez, Cristina Oliveras‐Ferraros, Sílvia Cufí, Bruna Corominas-Faja, Jorge Joven, Begoña Martı́n-Castillo, Alejandro Vázquez‐Martín · 2012 · Cell Cycle
  16. Spatial Heterogeneity in Drug Concentrations Can Facilitate the Emergence of Resistance to Cancer Therapy
    Feng Fu, Martin A. Nowak, Sebastian Bonhoeffer · 2015 · PLoS Computational Biology
  17. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling
    Xingbo Long, Wei Xiong, Xiting Zeng, Lin Qi, Yi Cai, Miao Mo, Huichuan Jiang, Bisong Zhu, Zhi Chen, Yuan Li · 2019 · Cell Death and Disease
  18. ROS: A “booster” for chronic inflammation and tumor metastasis
    Anqi Chen, Haifeng Huang, Sumeng Fang, Qinglei Hang · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  19. STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
    Looyenga, Brendan D., Hutchings, Danielle, Cherni, Irene, Kingsley, Chris, Weiss, Glen J., MacKeigan, Jeffrey P. · 2012 · PLoS ONE
  20. Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture
    Sarah-Louise Ryan, Anne‐Marie Baird, Gisela M. F. Vaz, Aaron J. Urquhart, Mathias O. Senge, Derek J. Richard, Kenneth John O'Byrne, Anthony Mitchell Davies · 2016 · Assay and Drug Development Technologies
  21. Alpha2beta1 integrin in cancer development and chemoresistance
    Dalila Naci, Kristiina Vuori, Fawzi Aoudjit · 2015 · Seminars in Cancer Biology
  22. ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells
    Jianye Cai, Jiancheng Wang, Yinong Huang, Hao‐Xiang Wu, Ting Xia, Jiaqi Xiao, Xiaoyong Chen, Hongyu Li, Yuan Qiu, Yingnan Wang et al. · 2016 · Cell Death and Disease
  23. Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids
    Yeonhwa Song, Se-Hyuk Kim, Kang Mo Kim, Eun Kyung Choi, Joon Kim, Haeng Ran Seo · 2016 · Scientific Reports
  24. Overcoming Drug Resistance and Treating Advanced Prostate Cancer
    Julius Semenas, Cinzia Allegrucci, Stephen Anthony Boorjian, Nigel Patrick Mongan, Jenny Liao Persson · 2012 · Current Drug Targets
  25. miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo
    Amy de Haar-Holleman, Ivy Chung, Rachelle R. Olsen, B Kwak, Atsushi Mizokami, Nagahiro Saijo, Amadeo Mark Parissenti, Zhenfeng Duan, Emile E. Voest, Bruce R. Zetter · 2011 · Oncogene
  26. Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
    Robert Cornelison, Danielle C. Llaneza, Charles N. Landen · 2017 · International Journal of Molecular Sciences
  27. Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
    Klára Szalontai, Nikolett Gémes, József Furák, Tünde Varga, Patrícia Neuperger, József Ágoston Balog, László G. Puskás, Gábor J. Szebeni · 2021 · Journal of Clinical Medicine
  28. OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
    Myriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, Bruno Bockorny, Laura Murias, Oliver Seifert, Stephan A. Eisler, Roland E. Kontermann, Klaus Pfizenmaier, So Young Lee et al. · 2020 · Clinical Cancer Research
  29. Extracellular Matrix Components and Mechanosensing Pathways in Health and Disease
    Aikaterini Berdiaki, Monica Teodora Neagu, Petros Tzanakakis, Ioanna Spyridaki, Serge Pérez, Dragana Nikitovic · 2024 · Biomolecules
  30. Application of Concave Microwells to Pancreatic Tumor Spheroids Enabling Anticancer Drug Evaluation in a Clinically Relevant Drug Resistance Model
    Yeon, Sang-Eun, No, Da Yoon, Lee, Sang-Hoon, Nam, Suk Woo, Oh, Il-Hoan, Lee, Jaehwi, Kuh, Hyo-Jeong · 2013 · PLoS ONE
  31. Role of the tumor microenvironment in mature B-cell lymphoid malignancies
    Nathan Hale Fowler, Chan Yoon Cheah, Randy D. Gascoyne, John G. Gribben, Sattva Swarup Neelapu, Paolo Ghia, Catherine M. Bollard, S. Ansell, Michael A. Curran, W. H. Wilson et al. · 2016 · Haematologica
  32. The role of CD44 in cancer chemoresistance: A concise review
    Zohreh Yaghobi, Ali Akbar Movassaghpour, Mehdi Talebi, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Shiva Pourvahdani, Behzad Baradaran · 2021 · European Journal of Pharmacology
  33. Intratumoral heterogeneity and drug resistance in cancer
    Yue-Chun Fu, Shao-Bo Liang, Min Luo, Xue‐Ping Wang · 2025 · Cancer Cell International
  34. Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
    Jagadish C. Ghosh, Markus David Siegelin, Valentina Vaira, Alice Faversani, Michele Tavecchio, Young Chan Chae, Sofia Lisanti, Paolo Maria Rampini, Massimo Giroda, M. Cecilia Caino et al. · 2015 · JNCI Journal of the National Cancer Institute
  35. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
    Li Zhang, Ling Pan, Bing Xiang, Huanling Zhu, Yu Wu, Meng Chen, Pujun Guan, Xingli Zou, C. Alexander Valencia, Biao Dong et al. · 2016 · Oncotarget
  36. The emerging roles of macrophages in cancer metastasis and response to chemotherapy
    Luis Rivera Sanchez, Lucia Borriello, David R. Entenberg, John S. Condeelis, Maja H. Oktay, George S. Karagiannis · 2019 · Journal of Leukocyte Biology
  37. Thermoneutrality, mice, and cancer: a heated opinion
    Hylander, Bonnie L., Repasky, Elizabeth A. · 2016 · Trends in cancer
  38. The impact of tumor stroma on drug response in breast cancer
    Jürgen Dittmer, Benjamin Leyh · 2014 · Seminars in Cancer Biology
  39. Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
    Sultan Alshehri, Syed Sarim Imam, Md. Rizwanullah, Sohail Akhter, Wael Ali Mahdi, Mohsin Kazi, Javed Ahmad · 2020 · Pharmaceutics
  40. Mechanisms of resistance to BCR–ABL TKIs and the therapeutic strategies: A review
    Ke Yang, Liwu Fu · 2014 · Critical Reviews in Oncology/Hematology
  41. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
    Tomas Koltai, Stephan J. Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone · 2022 · Cancers
  42. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
    Wang, Xudong, Li, Chang, Ju, Shaoqing, Wang, Yueguo, Wang, Huimin, Zhong, Renqian · 2011 · Leukemia & Lymphoma
  43. Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspective
    Ulrike Koch, Mechthild Krause, Michael A. Baumann · 2010 · Seminars in Cancer Biology
  44. Acute Myeloid Leukemia and the Bone Marrow Niche—Take a Closer Look
    Lena Behrmann, Jasmin Wellbrock, Walter Fiedler · 2018 · Frontiers in Oncology
  45. Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells
    Rebekka Müller, Kristine Misund, Toril Holien, Siri Bachke, Karin Margaretha Gilljam, Thea Kristin Våtsveen, Torstein Baade Rø, Emanuele Bellacchio, Anders Sundan, Marit Otterlei · 2013 · PLoS ONE
  46. Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters)
    Qi Yin, Jianan Shen, Lingli Chen, Zhiwen Zhang, Wangwen Gu, Yaping Li · 2012 · Biomaterials
  47. Chitosan-Alginate Scaffold Culture System for Hepatocellular Carcinoma Increases Malignancy and Drug Resistance
    Matthew C. Leung, Forrest M. Kievit, Stephen J. Florczyk, Omid Veiseh A, Jennifer D. Wu, James Oh Park, Miqin Zhang · 2010 · Pharmaceutical Research
  48. The tumor microenvironment shapes hallmarks of mature B-cell malignancies
    Kenneth H. Shain, William S. Dalton, Jianguo Tao · 2015 · Oncogene
  49. Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition
    Cristiana Perrotta, Davide Cervia, Ilaria Di Renzo, Claudia Moscheni, Maria Teresa Bassi, Lara Campana, Cristina Martelli, Elisabetta Catalani, Matteo Giovarelli, Silvia Zecchini et al. · 2018 · Frontiers in Immunology
  50. Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
    Sarah I. Bukhari, Syed Sarim Imam, Mohammad Zaki Ahmad, Parameswara Rao Vuddanda, Sultan Alshehri, Wael Ali Mahdi, Javed Ahmad · 2021 · Pharmaceutics
  51. Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance
    Xiuyun Xuan, Chunxia Tian, Mengjie Zhao, Yanhong Sun, Changzheng Huang · 2021 · Cancer Cell International
  52. Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia
    Mio Yamamoto‐Sugitani, Junya Kuroda, Eishi Ashihara, Hisao Nagoshi, Tsutomu Kobayashi, Yosuke Matsumoto, Nana Sasaki, Yuji Shimura, Miki Kiyota, Ryuko Nakayama et al. · 2011 · Proceedings of the National Academy of Sciences
  53. CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
    Jennifer Pasquier, Marie Gosset, Caroline Geyl, Jessica Hoarau-Véchot, Audrey Chevrot, Marc D. Pocard, Massoud Mirshahi, Raphaêl Lis, Arash Rafii, Cyril Touboul · 2018 · Molecular Cancer
  54. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment
    Ganesh Venkatraman, Matthew G.K. Benesch, Xiaoyun Tang, Jay W. Dewald, Todd P W McMullen, David N. Brindley · 2014 · The FASEB Journal
  55. Mesenchymal stem cells in the tumor microenvironment
    JIAN GUAN, Jie Chen · 2013 · Biomedical Reports
  56. Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments
    In‐Hye Ham, Dagyeong Lee, Hoon Hur · 2019 · Journal of Oncology
  57. STAT3 signaling in ovarian cancer: a potential therapeutic target
    Renba Liang, Xishan Chen, Li Chen, Fangzhu Wan, Kai-Hua Chen, Yongchu Sun, Xiaodong Zhu · 2019 · Journal of Cancer
  58. Cell-Autonomous and Non–Cell-Autonomous Mechanisms of HGF/MET–Driven Resistance to Targeted Therapies: From Basic Research to a Clinical Perspective
    Simona Corso, Silvia Giordano · 2013 · Cancer Discovery
  59. Follicular dendritic cell–dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion–mediated Bim down-regulation through induction of microRNA-181a
    Tint Lwin, Jianhong Lin, Yong Sung Choi, Xinwei Zhang, Lynn C. Moscinski, Kenneth L. Wright, Eduardo M. Sotomayor, William S. Dalton, Jianguo Tao · 2010 · Blood
  60. Development of an Acellular Tumor Extracellular Matrix as a Three-Dimensional Scaffold for Tumor Engineering
    Wei‐Dong Lü, Lei Zhang, Chunlin Wu, Zhi-Gang Liu, Guangyan Lei, Jia Liu, Wei Gao, Yerong Hu · 2014 · PLoS ONE
  61. Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis
    Juliana Barrera‐Ramirez, Jessie R. Lavoie, Harinad B. Maganti, William L. Stanford, Caryn Y. Ito, Mitchell Sabloff, Marjorie Brand, Michael Rosu‐Myles, Yevgeniya Le, David Allan · 2017 · Stem Cell Reviews and Reports
  62. Survivin in breast cancer–derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis
    Kangdi Li, Ting Liu, Jie Chen, Huying Ni, Wenhua Li · 2020 · Journal of Biological Chemistry
  63. NF-κB Regulates Radioresistance Mediated By β1-Integrin in Three-Dimensional Culture of Breast Cancer Cells
    Kazi Mokim Ahmed, Hui Zhang, Catherine C. Park · 2013 · Cancer Research
  64. Drug Targeting Strategies Based on Charge Dependent Uptake of Nanoparticles into Cancer Cells
    Saadat, Maryam, Zahednezhad, Fahimeh, Zakeri-Milani, Parvin, Reza Heidari, Hamid, Shahbazi-Mojarrad, Javid, Valizadeh, Hadi · 2019 · Journal of Pharmacy & Pharmaceutical Sciences
  65. Tumor Associated Macrophages Protect Colon Cancer Cells from TRAIL-Induced Apoptosis through IL-1β- Dependent Stabilization of Snail in Tumor Cells
    Pawan Kaler, Vincent P. Galea, Leonard H. Augenlicht, Lidija Klampfer · 2010 · PLoS ONE
  66. Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.
    Marta Geretto, Alessandra Pulliero, Camillo Rosano, Dinara Zhabayeva, Rakhmet I. Bersimbaev, Alberto Izzotti · 2017 · PubMed Central
  67. Cellular rewiring in lethal prostate cancer: the architect of drug resistance
    Marc Carceles‐Cordon, William Kevin Kelly, Leonard G. Gomella, Karen E. Knudsen, Verónica Rodríguez-Bravo, Josep M. Domingo Domenech · 2020 · Nature Reviews Urology
  68. JNK Signaling in Stem Cell Self-Renewal and Differentiation
    Takashi Semba, Rachel M. Sammons, Xiaoping Wang, Xuemei Xie, Kevin N. Dalby, Naoto Tada Ueno · 2020 · International Journal of Molecular Sciences
  69. Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
    Ling‐Jun Ho, Shue‐Fen Luo, Jenn‐Haung Lai · 2015 · Biochemical Pharmacology
  70. Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
    Inna V. Fedorenko, Ethan V. Abel, John M. Koomen, Bin Fang, Elizabeth R. Wood, Y. Ann Chen, Kate J. Fisher, Sushma Iyengar, Kimberly Brown Dahlman, Jennifer Ann Wargo et al. · 2015 · Oncogene
  71. Somatic clonal evolution: A selection-centric perspective
    Jacob G. Scott, Andriy Marusyk · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  72. Dissecting Variability in Responses to Cancer Chemotherapy Through Systems Pharmacology
    Robert Yang, Mario Niepel, TJ Mitchison, Peter Karl Sorger · 2010 · Clinical Pharmacology & Therapeutics
  73. Mesenchymal Stem Cells Provide an Advantageous Tumor Microenvironment for the Restoration of Cancer Stem Cells
    Kanako Nishimura, Shuho Semba, Kazuhiko Aoyagi, Hiroki Sasaki, Hiroshi Yokozaki · 2012 · Pathobiology
  74. Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
    Vishnu C. Ramani, Fenghuang Zhan, Jianbo He, Paola Barbieri, Alessandro Noseda, Guido J. K. Tricot, Ralph D. Sanderson · 2015 · Oncotarget
  75. Potential Application of Exosomes in Vaccine Development and Delivery
    Md Nurul Huda, Md Nurunnabi · 2022 · Pharmaceutical Research
  76. The brain tissue response to surgical injury and its possible contribution to glioma recurrence
    Lauriane Hamard, David Ratel, Laurent Selek, François R. Berger, Boudewijn P.J. van der Sanden, Didier Wion · 2016 · Journal of Neuro-Oncology
  77. Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers
    Faisal Raza, Hajra Zafar, Xinru You, Khan Asifullah, Jun Wu, Liang Ge · 2019 · Journal of Materials Chemistry B
  78. A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis
    Caifeng Liu, Yunjian Zhang, Sharon Lim, Kayoko Hosaka, Yunlong Yang, Tatiana V. Pavlova, Twana Alkasalias, Johan Hartman, Lasse D. Jensen, Xiaoming Xing et al. · 2017 · Clinical Cancer Research
  79. Tumour-microenvironmental interactions: paths to progression and targets for treatment
    Carol Box, Susanne J. Rogers, Marta Mendiola, Suzanne A. Eccles · 2010 · Seminars in Cancer Biology
  80. Mast Cells and Th17 Cells Contribute to the Lymphoma-Associated Pro-Inflammatory Microenvironment of Angioimmunoblastic T-Cell Lymphoma
    Claudio Tripodo, Giorgia Gri, Pier Paolo Piccaluga, Barbara Frossi, Carla Guarnotta, Silvia Piconese, Giovanni Maria Franco, Valeria Vetri, Carlo Ennio Michele Pucillo, Ada Maria Florena et al. · 2010 · American Journal Of Pathology
  81. xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies
    Jordi Martínez-Serra, Antonio M. Gutierrez, María Navarro-Palou, Teresa Ros, Juan Carlos Amat, Toni F. Marcús, Laura Fueyo, Angela García Suquia, Francisco Rubio, Joan Besalduch et al. · 2014 · OncoTargets and Therapy
  82. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis
    Hui Li, Fangying Xu, Si Li, Anjing Zhong, Xianwen Meng, Maode Lai · 2016 · Cell Adhesion & Migration
  83. Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
    Svetlana Miklikova, Miroslava Matúšková, Martin Boháč, Lenka Toro, Erika Durinikova, Silvia Tyčiaková, Lucia Demková, Ján Gurský, Lucia Kučerová · 2016 · Cell Communication and Signaling
  84. Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
    Elaheh Nasrollahzadeh, Sepideh Razi, Mahsa Keshavarz‐Fathi, Massimiliano Mazzone, Nima Rezaei · 2020 · Cancer Immunology Immunotherapy
  85. Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
    Maximilian Boesch, Sieghart Sopper, Alain Gustave Zeimet, Daniel Reimer, Guenther A. Gastl, Burkhard Ludewig, Dominik Georg Friedrich Wolf · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  86. Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment
    James M. Greene, Jana L. Gevertz, Eduardo D. Sontag · 2019 · JCO Clinical Cancer Informatics
  87. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
    Yiyi Yao, Fenglin Li, Jiansong Huang, Jie Jin, Huafeng Wang · 2021 · Experimental Hematology and Oncology
  88. Cancer-stromal interactions
    Wan Zhang, Peng Huang · 2011 · Cancer Biology & Therapy
  89. Evaluation of chemotherapeutics in a three-dimensional breast cancer model
    Carrie J. Lovitt, Todd Shelper, Vicky M. Avery · 2015 · Journal of Cancer Research and Clinical Oncology
  90. β1-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters
    Fabian Baltes, Vladlena Pfeifer, Katja Silbermann, Julia Caspers, Kathleen Wantoch von Rekowski, Martin Schlesinger, Gerd Bendas · 2020 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  91. Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
    Mark E. Issa, Farnaz Sedigheh Takhsha, Chandra Sekhar Chirumamilla, Claudina Angela Perez-Novo, Wim Vanden Berghe, Muriel Cuendet · 2017 · Clinical Epigenetics
  92. Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway
    Jun Ma, Xiao Song, Xiaowu Xu, Yiping Mou · 2018 · Cancer Research and Treatment
  93. Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives
    Haiquan Chen, Xinghua Cheng · 2014 · OncoTargets and Therapy
  94. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma
    Chunbao Zang, Xujie Liu, Bing Li, Yanqiong He, Shen Jing, Yujia He, Wenli Wu, Bingqian Zhang, Shuhong Ma, Weiwei Dai et al. · 2017 · Oncotarget
  95. Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference
    Daniel S.W. Tan, Marco Gerlinger, Bin Tean Teh, Charles Swanton · 2010 · European Journal of Cancer
  96. Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
    Meng Lei, Guanglan Ma, Sijia Sha, Xueyuan Wang, Haiting Feng, Yongqiang Zhu, Xiao Du · 2019 · Drug Delivery
  97. Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer
    Mans Broekgaarden, Sriram R. Anbil, Anne‐Laure Bulin, Girgis Obaid, Zhiming Mai, Yan Baglo, Imran Rizvi, Tayyaba G. Hasan · 2019 · Biomaterials
  98. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy
    Duojiao Wu, Diane C. Wang, Yunfeng Cheng, Mengjia Qian, Miaomiao Zhang, Qi Shen, Xiangdong Wang · 2016 · Seminars in Cancer Biology
  99. Cancer drug resistance: A fleet to conquer
    Showket Hussain, Ankita Singh, Sheeraz Un Nazir, Sonam Tulsyan, Asiya Khan, Ramesh Kumar, Nasreena Bashir, Pranay Tanwar, Ravi Mehrotra · 2019 · Journal of Cellular Biochemistry
  100. Spatial–temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness
    Shuya Yano, Yong Zhang, Shinji Miwa, Yasunori Tome, Yukihiko Hiroshima, Fuminari Uehara, Mako Yamamoto, Atsushi Suetsugu, Hiroyuki Kishimoto, Hiroshi Tazawa et al. · 2014 · Cell Cycle